Nevertheless, the potential use of glucagon for treating patients with PBH was tested using low-dose closed-loop infusion pumps that demonstrated to reduce the rates of hypoglycemia and prevent rebound hyperglycemia (16). The gene discussed is GCG; the disease is Hypoglycemia.